Global Neurodegenerative Diseases Drug Market Research Report 2016

December 2016 | 112 pages | ID: GACB8770027EN
QYResearch

Abstracts

Notes:

Production, means the output of Neurodegenerative Diseases Drug

Revenue, means the sales value of Neurodegenerative Diseases Drug

This report studies Neurodegenerative Diseases Drug in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

• Novartis
• Merck Serono
• Teva Pharmaceutical
• UCB
• Pfizer
• Biogen Idec
• Bayer Schering Pharma AG
• Boehringer Ingelheim
• Addex Pharmaceutical
• Amarin
• AstraZeneca
• Asubio Pharmaceutical
• Bial
• Alector
• Yumanity Therapeutics
• Eisai
• H.Lundbeck A/S
• Jiangsu Hansoh Pharmaceutical
• Yangtze River Pharmaceutical Group
• Chongqing Zein Pharmaceutical

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Neurodegenerative Diseases Drug in these regions, from 2011 to 2021 (forecast), like

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on consumption, market share and growth rate of Neurodegenerative Diseases Drug in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Neurodegenerative Diseases Drug Market Research Report 2016

1 NEURODEGENERATIVE DISEASES DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Neurodegenerative Diseases Drug
1.2 Neurodegenerative Diseases Drug Segment by Type
  1.2.1 Global Production Market Share of Neurodegenerative Diseases Drug by Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 Neurodegenerative Diseases Drug Segment by Application
  1.3.1 Neurodegenerative Diseases Drug Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Neurodegenerative Diseases Drug Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Neurodegenerative Diseases Drug (2011-2021)

2 GLOBAL NEURODEGENERATIVE DISEASES DRUG MARKET COMPETITION BY MANUFACTURERS

2.1 Global Neurodegenerative Diseases Drug Production and Share by Manufacturers (2015 and 2016)
2.2 Global Neurodegenerative Diseases Drug Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Neurodegenerative Diseases Drug Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Neurodegenerative Diseases Drug Manufacturing Base Distribution, Sales Area and Product Type
2.5 Neurodegenerative Diseases Drug Market Competitive Situation and Trends
  2.5.1 Neurodegenerative Diseases Drug Market Concentration Rate
  2.5.2 Neurodegenerative Diseases Drug Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL NEURODEGENERATIVE DISEASES DRUG PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Neurodegenerative Diseases Drug Production and Market Share by Region (2011-2016)
3.2 Global Neurodegenerative Diseases Drug Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Neurodegenerative Diseases Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Neurodegenerative Diseases Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Neurodegenerative Diseases Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Neurodegenerative Diseases Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Neurodegenerative Diseases Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Neurodegenerative Diseases Drug Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Neurodegenerative Diseases Drug Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL NEURODEGENERATIVE DISEASES DRUG SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Neurodegenerative Diseases Drug Consumption by Regions (2011-2016)
4.2 North America Neurodegenerative Diseases Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Neurodegenerative Diseases Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Neurodegenerative Diseases Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Neurodegenerative Diseases Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Neurodegenerative Diseases Drug Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Neurodegenerative Diseases Drug Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL NEURODEGENERATIVE DISEASES DRUG PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Neurodegenerative Diseases Drug Production and Market Share by Type (2011-2016)
5.2 Global Neurodegenerative Diseases Drug Revenue and Market Share by Type (2011-2016)
5.3 Global Neurodegenerative Diseases Drug Price by Type (2011-2016)
5.4 Global Neurodegenerative Diseases Drug Production Growth by Type (2011-2016)

6 GLOBAL NEURODEGENERATIVE DISEASES DRUG MARKET ANALYSIS BY APPLICATION

6.1 Global Neurodegenerative Diseases Drug Consumption and Market Share by Application (2011-2016)
6.2 Global Neurodegenerative Diseases Drug Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL NEURODEGENERATIVE DISEASES DRUG MANUFACTURERS PROFILES/ANALYSIS

7.1 Novartis
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Neurodegenerative Diseases Drug Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Novartis Neurodegenerative Diseases Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 Merck Serono
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Neurodegenerative Diseases Drug Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Merck Serono Neurodegenerative Diseases Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 Teva Pharmaceutical
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Neurodegenerative Diseases Drug Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Teva Pharmaceutical Neurodegenerative Diseases Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 UCB
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Neurodegenerative Diseases Drug Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 UCB Neurodegenerative Diseases Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Pfizer
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Neurodegenerative Diseases Drug Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Pfizer Neurodegenerative Diseases Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 Biogen Idec
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Neurodegenerative Diseases Drug Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Biogen Idec Neurodegenerative Diseases Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 Bayer Schering Pharma AG
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Neurodegenerative Diseases Drug Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Bayer Schering Pharma AG Neurodegenerative Diseases Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 Boehringer Ingelheim
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Neurodegenerative Diseases Drug Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Boehringer Ingelheim Neurodegenerative Diseases Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 Addex Pharmaceutical
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 Neurodegenerative Diseases Drug Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Addex Pharmaceutical Neurodegenerative Diseases Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview
7.10 Amarin
  7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.10.2 Neurodegenerative Diseases Drug Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Amarin Neurodegenerative Diseases Drug Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.10.4 Main Business/Business Overview
7.11 AstraZeneca
7.12 Asubio Pharmaceutical
7.13 Bial
7.14 Alector
7.15 Yumanity Therapeutics
7.16 Eisai
7.17 H.Lundbeck A/S
7.18 Jiangsu Hansoh Pharmaceutical
7.19 Yangtze River Pharmaceutical Group
7.20 Chongqing Zein Pharmaceutical

8 NEURODEGENERATIVE DISEASES DRUG MANUFACTURING COST ANALYSIS

8.1 Neurodegenerative Diseases Drug Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Neurodegenerative Diseases Drug

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Neurodegenerative Diseases Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Neurodegenerative Diseases Drug Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL NEURODEGENERATIVE DISEASES DRUG MARKET FORECAST (2016-2021)

12.1 Global Neurodegenerative Diseases Drug Production, Revenue Forecast (2016-2021)
12.2 Global Neurodegenerative Diseases Drug Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Neurodegenerative Diseases Drug Production Forecast by Type (2016-2021)
12.4 Global Neurodegenerative Diseases Drug Consumption Forecast by Application (2016-2021)
12.5 Neurodegenerative Diseases Drug Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Disclosure Section
Research Methodology
Data Source
China Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Neurodegenerative Diseases Drug
Figure Global Production Market Share of Neurodegenerative Diseases Drug by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Neurodegenerative Diseases Drug Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Neurodegenerative Diseases Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Neurodegenerative Diseases Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Neurodegenerative Diseases Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Neurodegenerative Diseases Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Neurodegenerative Diseases Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Neurodegenerative Diseases Drug Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Neurodegenerative Diseases Drug Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Neurodegenerative Diseases Drug Production of Key Manufacturers (2015 and 2016)
Table Global Neurodegenerative Diseases Drug Production Share by Manufacturers (2015 and 2016)
Figure 2015 Neurodegenerative Diseases Drug Production Share by Manufacturers
Figure 2016 Neurodegenerative Diseases Drug Production Share by Manufacturers
Table Global Neurodegenerative Diseases Drug Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Neurodegenerative Diseases Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Neurodegenerative Diseases Drug Revenue Share by Manufacturers
Table 2016 Global Neurodegenerative Diseases Drug Revenue Share by Manufacturers
Table Global Market Neurodegenerative Diseases Drug Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Neurodegenerative Diseases Drug Average Price of Key Manufacturers in 2015
Table Manufacturers Neurodegenerative Diseases Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Neurodegenerative Diseases Drug Product Type
Figure Neurodegenerative Diseases Drug Market Share of Top 3 Manufacturers
Figure Neurodegenerative Diseases Drug Market Share of Top 5 Manufacturers
Table Global Neurodegenerative Diseases Drug Production by Regions (2011-2016)
Figure Global Neurodegenerative Diseases Drug Production and Market Share by Regions (2011-2016)
Figure Global Neurodegenerative Diseases Drug Production Market Share by Regions (2011-2016)
Figure 2015 Global Neurodegenerative Diseases Drug Production Market Share by Regions
Table Global Neurodegenerative Diseases Drug Revenue by Regions (2011-2016)
Table Global Neurodegenerative Diseases Drug Revenue Market Share by Regions (2011-2016)
Table 2015 Global Neurodegenerative Diseases Drug Revenue Market Share by Regions
Table Global Neurodegenerative Diseases Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Neurodegenerative Diseases Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Neurodegenerative Diseases Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table China Neurodegenerative Diseases Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Neurodegenerative Diseases Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Neurodegenerative Diseases Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table India Neurodegenerative Diseases Drug Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Neurodegenerative Diseases Drug Consumption Market by Regions (2011-2016)
Table Global Neurodegenerative Diseases Drug Consumption Market Share by Regions (2011-2016)
Figure Global Neurodegenerative Diseases Drug Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Neurodegenerative Diseases Drug Consumption Market Share by Regions
Table North America Neurodegenerative Diseases Drug Production, Consumption, Import & Export (2011-2016)
Table Europe Neurodegenerative Diseases Drug Production, Consumption, Import & Export (2011-2016)
Table China Neurodegenerative Diseases Drug Production, Consumption, Import & Export (2011-2016)
Table Japan Neurodegenerative Diseases Drug Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Neurodegenerative Diseases Drug Production, Consumption, Import & Export (2011-2016)
Table India Neurodegenerative Diseases Drug Production, Consumption, Import & Export (2011-2016)
Table Global Neurodegenerative Diseases Drug Production by Type (2011-2016)
Table Global Neurodegenerative Diseases Drug Production Share by Type (2011-2016)
Figure Production Market Share of Neurodegenerative Diseases Drug by Type (2011-2016)
Figure 2015 Production Market Share of Neurodegenerative Diseases Drug by Type
Table Global Neurodegenerative Diseases Drug Revenue by Type (2011-2016)
Table Global Neurodegenerative Diseases Drug Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Neurodegenerative Diseases Drug by Type (2011-2016)
Figure 2015 Revenue Market Share of Neurodegenerative Diseases Drug by Type
Table Global Neurodegenerative Diseases Drug Price by Type (2011-2016)
Figure Global Neurodegenerative Diseases Drug Production Growth by Type (2011-2016)
Table Global Neurodegenerative Diseases Drug Consumption by Application (2011-2016)
Table Global Neurodegenerative Diseases Drug Consumption Market Share by Application (2011-2016)
Figure Global Neurodegenerative Diseases Drug Consumption Market Share by Application in 2015
Table Global Neurodegenerative Diseases Drug Consumption Growth Rate by Application (2011-2016)
Figure Global Neurodegenerative Diseases Drug Consumption Growth Rate by Application (2011-2016)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Neurodegenerative Diseases Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Neurodegenerative Diseases Drug Market Share (2011-2016)
Table Merck Serono Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Serono Neurodegenerative Diseases Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Serono Neurodegenerative Diseases Drug Market Share (2011-2016)
Table Teva Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Pharmaceutical Neurodegenerative Diseases Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Teva Pharmaceutical Neurodegenerative Diseases Drug Market Share (2011-2016)
Table UCB Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table UCB Neurodegenerative Diseases Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure UCB Neurodegenerative Diseases Drug Market Share (2011-2016)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Neurodegenerative Diseases Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Neurodegenerative Diseases Drug Market Share (2011-2016)
Table Biogen Idec Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biogen Idec Neurodegenerative Diseases Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Biogen Idec Neurodegenerative Diseases Drug Market Share (2011-2016)
Table Bayer Schering Pharma AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Schering Pharma AG Neurodegenerative Diseases Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer Schering Pharma AG Neurodegenerative Diseases Drug Market Share (2011-2016)
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim Neurodegenerative Diseases Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Boehringer Ingelheim Neurodegenerative Diseases Drug Market Share (2011-2016)
Table Addex Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Addex Pharmaceutical Neurodegenerative Diseases Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Addex Pharmaceutical Neurodegenerative Diseases Drug Market Share (2011-2016)
Table Amarin Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amarin Neurodegenerative Diseases Drug Production, Revenue, Price and Gross Margin (2011-2016)
Figure Amarin Neurodegenerative Diseases Drug Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Neurodegenerative Diseases Drug
Figure Manufacturing Process Analysis of Neurodegenerative Diseases Drug
Figure Neurodegenerative Diseases Drug Industrial Chain Analysis
Table Raw Materials Sources of Neurodegenerative Diseases Drug Major Manufacturers in 2015
Table Major Buyers of Neurodegenerative Diseases Drug
Table Distributors/Traders List
Figure Global Neurodegenerative Diseases Drug Production and Growth Rate Forecast (2016-2021)
Figure Global Neurodegenerative Diseases Drug Revenue and Growth Rate Forecast (2016-2021)
Table Global Neurodegenerative Diseases Drug Production Forecast by Regions (2016-2021)
Table Global Neurodegenerative Diseases Drug Consumption Forecast by Regions (2016-2021)
Table Global Neurodegenerative Diseases Drug Production Forecast by Type (2016-2021)
Table Global Neurodegenerative Diseases Drug Consumption Forecast by Application (2016-2021)